黑色素-话题@MedSci - williamhill asia

#黑色素#

1110篇内容 | 4716人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1565163, encodeId=fa071565163ff, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析, objectType=article, longId=739238, objectId=6a95e39238e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a95e39238e9, replyNumber=0, likeNumber=75, createdTime=2022-09-15, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a95e39238e9, moduleTitle=JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6a95e39238e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559154, encodeId=60af15591540d, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析, objectType=article, longId=739238, objectId=6a95e39238e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a95e39238e9, replyNumber=0, likeNumber=96, createdTime=2022-09-15, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a95e39238e9, moduleTitle=JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6a95e39238e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565164, encodeId=6c6e156516442, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用, objectType=article, longId=739109, objectId=f048e391092c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f048e391092c, replyNumber=0, likeNumber=113, createdTime=2022-09-14, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f048e391092c, moduleTitle=Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f048e391092c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559155, encodeId=8905155915568, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用, objectType=article, longId=739109, objectId=f048e391092c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f048e391092c, replyNumber=0, likeNumber=0, createdTime=2022-09-14, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f048e391092c, moduleTitle=Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f048e391092c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565161, encodeId=e5c815651610f, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, objectType=article, longId=738461, objectId=299ee38461f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299ee38461f3, replyNumber=0, likeNumber=91, createdTime=2022-09-08, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299ee38461f3, moduleTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=299ee38461f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559152, encodeId=ece01559152aa, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, objectType=article, longId=738461, objectId=299ee38461f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299ee38461f3, replyNumber=0, likeNumber=69, createdTime=2022-09-08, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299ee38461f3, moduleTitle=EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=299ee38461f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565162, encodeId=24b01565162fe, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, objectType=article, longId=738383, objectId=e5a2e3838337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a2e3838337, replyNumber=0, likeNumber=128, createdTime=2022-09-08, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a2e3838337, moduleTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e5a2e3838337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559153, encodeId=22e1155915324, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, objectType=article, longId=738383, objectId=e5a2e3838337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a2e3838337, replyNumber=0, likeNumber=91, createdTime=2022-09-08, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a2e3838337, moduleTitle=Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e5a2e3838337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565160, encodeId=a7231565160a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤, objectType=article, longId=737805, objectId=47e8e378058e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e8e378058e, replyNumber=0, likeNumber=92, createdTime=2022-09-06, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e8e378058e, moduleTitle=Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=47e8e378058e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559151, encodeId=19921559151f6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤, objectType=article, longId=737805, objectId=47e8e378058e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e8e378058e, replyNumber=0, likeNumber=80, createdTime=2022-09-06, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e8e378058e, moduleTitle=Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=47e8e378058e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565159, encodeId=66a7156515942, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤, objectType=article, longId=737793, objectId=5560e37793d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5560e37793d5, replyNumber=0, likeNumber=93, createdTime=2022-09-06, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5560e37793d5, moduleTitle=J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5560e37793d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559150, encodeId=edc515591506d, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤, objectType=article, longId=737793, objectId=5560e37793d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5560e37793d5, replyNumber=0, likeNumber=82, createdTime=2022-09-06, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5560e37793d5, moduleTitle=J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5560e37793d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559149, encodeId=96ea1559149f7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, objectType=article, longId=736665, objectId=88b3e36665f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88b3e36665f7, replyNumber=0, likeNumber=107, createdTime=2022-08-24, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88b3e36665f7, moduleTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=88b3e36665f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565158, encodeId=3c6d156515870, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, objectType=article, longId=736665, objectId=88b3e36665f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88b3e36665f7, replyNumber=0, likeNumber=86, createdTime=2022-08-24, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88b3e36665f7, moduleTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=88b3e36665f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559148, encodeId=fb421559148b6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, objectType=article, longId=735611, objectId=29e0e3561170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0e3561170, replyNumber=0, likeNumber=85, createdTime=2022-08-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0e3561170, moduleTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=29e0e3561170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565157, encodeId=f4eb156515eb9, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, objectType=article, longId=735611, objectId=29e0e3561170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0e3561170, replyNumber=0, likeNumber=83, createdTime=2022-08-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0e3561170, moduleTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=29e0e3561170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559147, encodeId=e3f0155914ea4, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=肤色的决定因素—黑色素, objectType=article, longId=735557, objectId=69eae355578d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69eae355578d, replyNumber=0, likeNumber=85, createdTime=2022-08-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69eae355578d, moduleTitle=肤色的决定因素—黑色素, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=69eae355578d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565156, encodeId=d999156515647, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=肤色的决定因素—黑色素, objectType=article, longId=735557, objectId=69eae355578d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69eae355578d, replyNumber=0, likeNumber=90, createdTime=2022-08-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69eae355578d, moduleTitle=肤色的决定因素—黑色素, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=69eae355578d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559146, encodeId=9e72155914666, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, objectType=article, longId=735293, objectId=8390e3529363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390e3529363, replyNumber=0, likeNumber=84, createdTime=2022-08-10, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390e3529363, moduleTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8390e3529363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565155, encodeId=83a3156515501, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, objectType=article, longId=735293, objectId=8390e3529363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390e3529363, replyNumber=0, likeNumber=85, createdTime=2022-08-10, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390e3529363, moduleTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8390e3529363)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

黑色素

2020-05-29

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析

2022-09-15

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

JAMA Dermatol：低剂量甲氨蝶呤暴露与黑色素瘤的相关性，系统综述和荟萃分析

2022-09-15

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用

2022-09-14

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Adv Ther：计划行为理论在黑色素瘤切除患者坚持辅助治疗中的应用

2022-09-14

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制

2022-09-08

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

EJCB：王福俤团队揭示锌离子稳态调控黑色素细胞增殖新机制

2022-09-08

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征

2022-09-08

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Exp Dermatol ：类似黑色素瘤的基底细胞癌的皮肤镜特征

2022-09-08

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤

2022-09-06

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Clin Cancer Res：阿特珠单抗联合贝伐单抗治疗晚期黏膜黑色素瘤

2022-09-06

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤

2022-09-06

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

J Clin Oncol：Talimogene Laherparepvec联合派姆单抗治疗晚期黑色素瘤

2022-09-06

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究

2022-08-24

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究

2022-08-24

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加

2022-08-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加

2022-08-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

肤色的决定因素—黑色素

2022-08-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

肤色的决定因素—黑色素

2022-08-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤

2022-08-10

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤

2022-08-10

科室
- - 订阅+
  - 更多科室
工具
服务